Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Genest

Showing results (51-60 of 214) with videos related to

Pageof 22
Sort By:
Current Atherosclerosis Reports|August 19, 2008
Effect of ABCA1 mutations on risk for myocardial infarctionIulia Iatan, Khalid Alrasadi, Isabelle Ruel, et al.
The American Journal of Cardiology|November 12, 2013
High-density lipoprotein mediated cellular cholesterol efflux in acute coronary syndromesAnouar Hafiane, Bashar Jabor, Isabelle Ruel, et al.
Plos One|July 25, 2015
Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In VitroAnouar Hafiane, John K Bielicki, Jan O Johansson, et al.
Pediatric Nephrology (Berlin, Germany)|August 13, 2002
Plasma homocysteine concentration changes after renal transplantation in childrenAicha Merouani, Edgar E Delvin, Jacques Genest, et al.
Journal of Lipid Research|March 3, 2005
ESI-MS quantitation of increased sphingomyelin in Niemann-Pick disease type B HDLChing Yin Lee, Alain Lesimple, Asmund Larsen, et al.
CMAJ Open|August 22, 2023
Genetic testing for familial hypercholesterolemia in Quebec, Canada: a single-centre retrospective cohort studyAmanda Guerin, Iulia Iatan, Isabelle Ruel, et al.
The Canadian Journal of Cardiology|September 15, 2006
Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular diseaseRuth McPherson, Jiri Frohlich, George Fodor, et al.
Biomedicines|February 25, 2023
Biomedical Advances in ABCA1 Transporter: From Bench to BedsideHong Y Choi, Senna Choi, Iulia Iatan, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2004
Is the decreased high-density lipoprotein cholesterol in the metabolic syndrome due to cellular lipid efflux defect?Mohammad Y Alenezi, Michel Marcil, David Blank, et al.
The Canadian Journal of Cardiology|February 25, 2006
Cellular cholesterol homeostasis in vascular endothelial cellsHajj Hassan Hassan, Maxime Denis, Larbi Krimbou, et al.
Pageof 22

Showing results (51-60 of 214) with videos related to

Sort By:
Pageof 22
Current Atherosclerosis Reports|August 19, 2008
Effect of ABCA1 mutations on risk for myocardial infarctionIulia Iatan, Khalid Alrasadi, Isabelle Ruel, et al.
The American Journal of Cardiology|November 12, 2013
High-density lipoprotein mediated cellular cholesterol efflux in acute coronary syndromesAnouar Hafiane, Bashar Jabor, Isabelle Ruel, et al.
Plos One|July 25, 2015
Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In VitroAnouar Hafiane, John K Bielicki, Jan O Johansson, et al.
Pediatric Nephrology (Berlin, Germany)|August 13, 2002
Plasma homocysteine concentration changes after renal transplantation in childrenAicha Merouani, Edgar E Delvin, Jacques Genest, et al.
Journal of Lipid Research|March 3, 2005
ESI-MS quantitation of increased sphingomyelin in Niemann-Pick disease type B HDLChing Yin Lee, Alain Lesimple, Asmund Larsen, et al.
CMAJ Open|August 22, 2023
Genetic testing for familial hypercholesterolemia in Quebec, Canada: a single-centre retrospective cohort studyAmanda Guerin, Iulia Iatan, Isabelle Ruel, et al.
The Canadian Journal of Cardiology|September 15, 2006
Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular diseaseRuth McPherson, Jiri Frohlich, George Fodor, et al.
Biomedicines|February 25, 2023
Biomedical Advances in ABCA1 Transporter: From Bench to BedsideHong Y Choi, Senna Choi, Iulia Iatan, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2004
Is the decreased high-density lipoprotein cholesterol in the metabolic syndrome due to cellular lipid efflux defect?Mohammad Y Alenezi, Michel Marcil, David Blank, et al.
The Canadian Journal of Cardiology|February 25, 2006
Cellular cholesterol homeostasis in vascular endothelial cellsHajj Hassan Hassan, Maxime Denis, Larbi Krimbou, et al.
Pageof 22